<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35874528</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-042X</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in physiology</Title><ISOAbbreviation>Front Physiol</ISOAbbreviation></Journal><ArticleTitle>Persistent dyspnea after COVID-19 is not related to cardiopulmonary impairment; a cross-sectional study of persistently dyspneic COVID-19, non-dyspneic COVID-19 and controls.</ArticleTitle><Pagination><StartPage>917886</StartPage><MedlinePgn>917886</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">917886</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fphys.2022.917886</ELocationID><Abstract><AbstractText><b>Background:</b> Up to 53% of individuals who had mild COVID-19 experience symptoms for &gt;3-month following infection (Long-CoV). Dyspnea is reported in 60% of Long-CoV cases and may be secondary to impaired exercise capacity (VO<sub>2peak</sub>) as a result of pulmonary, pulmonary vascular, or cardiac insult. This study examined whether cardiopulmonary mechanisms could explain exertional dyspnea in Long-CoV. <b>Methods:</b> A cross-sectional study of participants with Long-CoV (n = 28, age 40 &#xb1; 11&#xa0;years, 214 &#xb1; 85&#xa0;days post-infection) and age- sex- and body mass index-matched COVID-19 na&#xef;ve controls (Con, n = 24, age 41 &#xb1; 12&#xa0;years) and participants fully recovered from COVID-19 (ns-CoV, n = 14, age 37 &#xb1; 9&#xa0;years, 198 &#xb1; 89&#xa0;days post-infection) was conducted. Participants self-reported symptoms and baseline dyspnea (modified Medical Research Council, mMRC, dyspnea grade), then underwent a comprehensive pulmonary function test, cardiopulmonary exercise test, exercise pulmonary diffusing capacity measurement, and rest and exercise echocardiography. <b>Results:</b> VO<sub>2peak</sub>, pulmonary function and cardiac/pulmonary vascular parameters were not impaired in Long- or ns-CoV compared to normative values (VO<sub>2peak</sub>: 106 &#xb1; 25 and 107 &#xb1; 25%<sub>predicted</sub>, respectively) and cardiopulmonary responses to exercise were otherwise normal. When Long-CoV were stratified by clinical dyspnea severity (mMRC = 0 vs mMRC&#x2265;1), there were no between-group differences in VO<sub>2peak</sub>. During submaximal exercise, dyspnea and ventilation were increased in the mMRC&#x2265;1 group, despite normal operating lung volumes, arterial saturation, diffusing capacity and indicators of pulmonary vascular pressures. <b>Interpretation:</b> Persistent dyspnea after COVID-19 was not associated with overt cardiopulmonary impairment or exercise intolerance. Interventions focusing on dyspnea management may be appropriate for Long-CoV patients who report dyspnea without cardiopulmonary impairment.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Beaudry, Brotto, Varughese, de Waal, Fuhr, Damant, Ferrara, Lam, Smith and Stickland.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Beaudry</LastName><ForeName>Rhys I</ForeName><Initials>RI</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brotto</LastName><ForeName>Andrew R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varughese</LastName><ForeName>Rhea A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Waal</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuhr</LastName><ForeName>Desi P</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Damant</LastName><ForeName>Ronald W</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrara</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lam</LastName><ForeName>Grace Y</ForeName><Initials>GY</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Maeve P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stickland</LastName><ForeName>Michael K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>G.F. MacDonald Centre for Lung Health, Covenant Health, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Physiol</MedlineTA><NlmUniqueID>101549006</NlmUniqueID><ISSNLinking>1664-042X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DLCO</Keyword><Keyword MajorTopicYN="N">VO2</Keyword><Keyword MajorTopicYN="N">long-covid</Keyword><Keyword MajorTopicYN="N">maximal oxygen consumption</Keyword><Keyword MajorTopicYN="N">pulmonary function</Keyword><Keyword MajorTopicYN="N">pulmonary vascular</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>25</Day><Hour>3</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35874528</ArticleId><ArticleId IdType="pmc">PMC9297912</ArticleId><ArticleId IdType="doi">10.3389/fphys.2022.917886</ArticleId><ArticleId IdType="pii">917886</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Anastasio F., Barbuto S., Scarnecchia E., Cosma P., Fugagnoli A., Rossi G., et al. (2021). Medium-term impact of COVID-19 on pulmonary function, functional capacity and quality of life. Eur. Respir. J. 58, 2004015. 10.1183/13993003.04015-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.04015-2020</ArticleId><ArticleId IdType="pmc">PMC7877327</ArticleId><ArticleId IdType="pubmed">33574080</ArticleId></ArticleIdList></Reference><Reference><Citation>Arena R., Myers J., Aslam S. S., Varughese E. B., Peberdy M. A. (2004). Peak VO2 and VE/VCO2 slope in patients with heart failure: a prognostic comparison. Am. Heart J. 147 (2), 354&#x2013;360. 10.1016/j.ahj.2003.07.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2003.07.014</ArticleId><ArticleId IdType="pubmed">14760336</ArticleId></ArticleIdList></Reference><Reference><Citation>Arena R., Sietsema K. E. (2011). Cardiopulmonary exercise testing in the clinical evaluation of patients with heart and lung disease. Circulation 123 (6), 668&#x2013;680. 10.1161/circulationaha.109.914788</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circulationaha.109.914788</ArticleId><ArticleId IdType="pubmed">21321183</ArticleId></ArticleIdList></Reference><Reference><Citation>Borg G. A. V. (1982). Psychophysical bases of perceived exertion. Med. Sci. Sports Exerc. 14 (5), 377&#x2013;381. 10.1249/00005768-198205000-00012</Citation><ArticleIdList><ArticleId IdType="doi">10.1249/00005768-198205000-00012</ArticleId><ArticleId IdType="pubmed">7154893</ArticleId></ArticleIdList></Reference><Reference><Citation>Byers B. W., Fuhr D. P., Moore L. E., Bhutani M., Wong E. Y. L., Stickland M. K. (2019). The effect of pulmonary rehabilitation on carotid chemoreceptor activity and sensitivity in chronic obstructive pulmonary disease. J. Appl. Physiol. 127 (5), 1278&#x2013;1287. 10.1152/japplphysiol.00799.2018</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00799.2018</ArticleId><ArticleId IdType="pubmed">31295067</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F., and Gemelli Against COVID-19 Post-Acute Care Study Group (2020). Persistent symptoms in patients after acute COVID-19. JAMA 324 (6), 603&#x2013;605. 10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Clavario P., De Marzo V., Lotti R., Barbara C., Porcile A., Russo C., et al. (2020). Assessment of functional capacity with cardiopulmonary exercise testing in non-severe COVID-19 patients at three months follow-up. medRxiv. 10.1101/2020.11.15.20231985</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.11.15.20231985</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H. E., Assaf G. S., McCorkell L., Wei H., Low R. J., Re'em Y., et al. (2021). Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 38, 101019. 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Faisal A., Alghamdi B. J., Ciavaglia C. E., Elbehairy A. F., Webb K. A., Ora J., et al. (2015). Common mechanisms of dyspnea in chronic interstitial and obstructive lung disorders. Am. J. Respir. Crit. Care Med. 193 (3), 299&#x2013;309. 10.1164/rccm.201504-0841OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201504-0841OC</ArticleId><ArticleId IdType="pubmed">26407036</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli A., Misuraca C., Bianchi A., Borsa N., Limonta S., Maggiolini S., et al. (2021). Long-term changes in pulmonary function among patients surviving to COVID-19 pneumonia. Infection [Epub ahead of print], 1&#x2013;4. 10.1007/s15010-021-01718-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01718-2</ArticleId><ArticleId IdType="pmc">PMC8517554</ArticleId><ArticleId IdType="pubmed">34652626</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham B. L., Brusasco V., Burgos F., Cooper B. G., Jensen R., Kendrick A., et al. (2017). 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung. Eur. Respir. J. 49 (1), 1600016. 10.1183/13993003.00016-2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00016-2016</ArticleId><ArticleId IdType="pubmed">28049168</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham B. L., Steenbruggen I., Miller M. R., Barjaktarevic I. Z., Cooper B. G., Hall G. L., et al. (2019). Standardization of spirometry 2019 update. An official american thoracic society and european respiratory society technical statement. Am. J. Respir. Crit. Care Med. 200 (8), e70&#x2013;e88. 10.1164/rccm.201908-1590st</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201908-1590st</ArticleId><ArticleId IdType="pmc">PMC6794117</ArticleId><ArticleId IdType="pubmed">31613151</ArticleId></ArticleIdList></Reference><Reference><Citation>Guenette J. A., Chin R. C., Cheng S., Dominelli P. B., Raghavan N., Webb K. A., et al. (2014). Mechanisms of exercise intolerance in global initiative for chronic obstructive lung disease grade 1 COPD. Eur. Respir. J. 44 (5), 1177&#x2013;1187. 10.1183/09031936.00034714</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00034714</ArticleId><ArticleId IdType="pubmed">25142487</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulati M., Pandey D. K., Arnsdorf M. F., Lauderdale D. S., Thisted R. A., Wicklund R. H., et al. (2003). Exercise capacity and the risk of death in women: the St James women take heart project. Circulation 108 (13), 1554&#x2013;1559. 10.1161/01.cir.0000091080.57509.e9</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.0000091080.57509.e9</ArticleId><ArticleId IdType="pubmed">12975254</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall G. L., Filipow N., Ruppel G., Okitika T., Thompson B., Kirkby J., et al. (2021). Official ERS technical standard: global lung function initiative reference values for static lung volumes in individuals of european ancestry. Eur. Respir. J. 57 (3), 2000289. 10.1183/13993003.00289-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00289-2020</ArticleId><ArticleId IdType="pubmed">33707167</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen J. E., Wasserman K. (1996). Pathophysiology of activity limitation in patients with interstitial lung disease. Chest 109 (6), 1566&#x2013;1576. 10.1378/chest.109.6.1566</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.109.6.1566</ArticleId><ArticleId IdType="pubmed">8769513</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman M., Gudex C., Lloyd A., Janssen M., Kind P., Parkin D., et al. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual. Life Res. 20 (10), 1727&#x2013;1736. 10.1007/s11136-011-9903-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-011-9903-x</ArticleId><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahn K., Sava M., Sommer G., Schumann D. M., Bassetti S., Siegemund M., et al. (2021). Exercise capacity impairment after COVID-19 pneumonia is mainly caused by deconditioning. Eur. Respir. J. 59, 2101136. 10.1183/13993003.01136-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01136-2021</ArticleId><ArticleId IdType="pmc">PMC8573604</ArticleId><ArticleId IdType="pubmed">34737222</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok F. A., Boon G. J. A. M., Barco S., Endres M., Miranda Geelhoed J. J., Knauss S., et al. (2020). The post-COVID-19 functional status (PCFS) scale: a tool to measure functional status over time after COVID-19. Eur. Respir. J. 56, 2001494. 10.1183/13993003.01494-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01494-2020</ArticleId><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam G. Y., Befus A. D., Damant R. W., Ferrara G., Fuhr D. P., Stickland M. K., et al. (2021). Exertional intolerance and dyspnea with preserved lung function: an emerging long COVID phenotype? Respir. Res. 22 (1), 222. 10.1186/s12931-021-01814-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-021-01814-9</ArticleId><ArticleId IdType="pmc">PMC8343348</ArticleId><ArticleId IdType="pubmed">34362372</ArticleId></ArticleIdList></Reference><Reference><Citation>Laveneziana P., Garcia G., Joureau B., Nicolas-Jilwan F., Brahimi T., Laviolette L., et al. (2013). Dynamic respiratory mechanics and exertional dyspnoea in pulmonary arterial hypertension. Eur. Respir. J. 41 (3), 578&#x2013;587. 10.1183/09031936.00223611</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00223611</ArticleId><ArticleId IdType="pubmed">22790921</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerum T. V., Aal&#xf8;kken T. M., Br&#xf8;nstad E., Aarli B., Ikdahl E., Lund K. M. A., et al. (2021). Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19. Eur. Respir. J. 57 (4), 2003448. 10.1183/13993003.03448-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03448-2020</ArticleId><ArticleId IdType="pmc">PMC7736755</ArticleId><ArticleId IdType="pubmed">33303540</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewthwaite H., Benedetti A., Stickland M. K., Bourbeau J., Guenette J. A., Maltais F., et al. (2020). Normative peak cardiopulmonary exercise test responses in canadian adults aged &#x2265;40 years. Chest 158 (6), 2532&#x2013;2545. 10.1016/j.chest.2020.06.074</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2020.06.074</ArticleId><ArticleId IdType="pubmed">32679236</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahler D. A., Wells C. K. (1988). Evaluation of clinical methods for rating dyspnea. Chest 93 (3), 580&#x2013;586. 10.1378/chest.93.3.580</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.93.3.580</ArticleId><ArticleId IdType="pubmed">3342669</ArticleId></ArticleIdList></Reference><Reference><Citation>Matta J., Wiernik E., Robineau O., Carrat F., Touvier M., Severi G., et al. (2022). Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among french adults during the COVID-19 pandemic. JAMA Intern Med. 182 (1), 19&#x2013;25. 10.1001/jamainternmed.2021.6454</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2021.6454</ArticleId><ArticleId IdType="pmc">PMC8576624</ArticleId><ArticleId IdType="pubmed">34747982</ArticleId></ArticleIdList></Reference><Reference><Citation>Metlay J. P., Fine M. J., Schulz R., Marrie T. J., Coley C. M., Kapoor W. N., et al. (1997). Measuring symptomatic and functional recovery in patients with community-acquired pneumonia. J. Gen. Intern Med. 12 (7), 423&#x2013;430. 10.1046/j.1525-1497.1997.00074.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1525-1497.1997.00074.x</ArticleId><ArticleId IdType="pmc">PMC1497132</ArticleId><ArticleId IdType="pubmed">9229281</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell C., Rahko P. S., Blauwet L. A., Canaday B., Finstuen J. A., Foster M. C., et al. (2019). Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the american society of echocardiography. J. Am. Soc. Echocardiogr. 32 (1), 1&#x2013;64. 10.1016/j.echo.2018.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2018.06.004</ArticleId><ArticleId IdType="pubmed">30282592</ArticleId></ArticleIdList></Reference><Reference><Citation>Motiejunaite J., Balagny P., Arnoult F., Mangin L., Bancal C., d&#x2019;Ortho M.-P., et al. (2021). Hyperventilation: a Possible explanation for long-lasting exercise intolerance in mild COVID-19 survivors? Front. Physiol. 11, 614590. 10.3389/fphys.2020.614590</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.614590</ArticleId><ArticleId IdType="pmc">PMC7849606</ArticleId><ArticleId IdType="pubmed">33536937</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers J., Prakash M., Froelicher V., Do D., Partington S., Atwood J. E. (2002). Exercise capacity and mortality among men referred for exercise testing. N. Engl. J. Med. 346 (11), 793&#x2013;801. 10.1056/nejmoa011858</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa011858</ArticleId><ArticleId IdType="pubmed">11893790</ArticleId></ArticleIdList></Reference><Reference><Citation>Neder J. A., Alharbi A., Berton D. C., Alencar M. C. N., Arbex F. F., Hirai D. M., et al. (2016). Exercise ventilatory inefficiency adds to lung function in predicting mortality in COPD. COPD J. Chronic Obstr. Pulm. Dis. 13 (4), 416&#x2013;424. 10.3109/15412555.2016.1158801</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/15412555.2016.1158801</ArticleId><ArticleId IdType="pubmed">27077955</ArticleId></ArticleIdList></Reference><Reference><Citation>Neder J. A., Nery L. E., Castelo A., Andreoni S., Lerario M. C., Sachs A., et al. (1999). Prediction of metabolic and cardiopulmonary responses to maximum cycle ergometry: a randomised study. Eur. Respir. J. 14 (6), 1304&#x2013;1313. 10.1183/09031936.99.14613049</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.99.14613049</ArticleId><ArticleId IdType="pubmed">10624759</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Donnell D. E., Elbehairy A. F., Webb K. A., Neder J. A. (2017). The link between reduced inspiratory capacity and exercise intolerance in chronic obstructive pulmonary disease. Ann. Am. Thorac. Soc. 14 (Suppl_1), S30&#x2013;S39. 10.1513/AnnalsATS.201610-834FR</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.201610-834FR</ArticleId><ArticleId IdType="pubmed">28398073</ArticleId></ArticleIdList></Reference><Reference><Citation>Obokata M., Olson T. P., Reddy Y. N. V., Melenovsky V., Kane G. C., Borlaug B. A. (2018). Haemodynamics, dyspnoea, and pulmonary reserve in heart failure with preserved ejection fraction. Eur. heart J. 39 (30), 2810&#x2013;2821. 10.1093/eurheartj/ehy268</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy268</ArticleId><ArticleId IdType="pmc">PMC6658816</ArticleId><ArticleId IdType="pubmed">29788047</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen M. S., Kristiansen M. F., Hanusson K. D., Danielsen M. E., &#xc1; Steig B., Gaini S., et al. (2020). Long COVID in the Faroe Islands - a longitudinal study among non-hospitalized patients. Clin. Infect. Dis. 73 (11), e4058&#x2013;e4063. 10.1093/cid/ciaa1792</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips D. B., Brotto A. R., Ross B. A., Bryan T. L., Wong E. Y. L., Meah V. L., et al. (2021). Inhaled nitric oxide improves ventilatory efficiency and exercise capacity in patients with mild COPD: a randomized&#x2010;control cross&#x2010;over trial. J. Physiol. 599 (5), 1665&#x2013;1683. 10.1113/jp280913</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jp280913</ArticleId><ArticleId IdType="pubmed">33428233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponikowski P., Chua T. P., Anker S. D., Francis D. P., Doehner W., Banasiak W., et al. (2001). Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure. Circulation 104 (5), 544&#x2013;549. 10.1161/hc3101.093699</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/hc3101.093699</ArticleId><ArticleId IdType="pubmed">11479251</ArticleId></ArticleIdList></Reference><Reference><Citation>Radtke T., Crook S., Kaltsakas G., Louvaris Z., Berton D., Urquhart D. S., et al. (2019). ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseases. Eur. Respir. Rev. 28 (154), 180101. 10.1183/16000617.0101-2018</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0101-2018</ArticleId><ArticleId IdType="pmc">PMC9488712</ArticleId><ArticleId IdType="pubmed">31852745</ArticleId></ArticleIdList></Reference><Reference><Citation>Shouman K., Vanichkachorn G., Cheshire W. P., Suarez M. D., Shelly S., Lamotte G. J., et al. (2021). Autonomic dysfunction following COVID-19 infection: an early experience. Clin. Auton. Res. 31 (3), 385&#x2013;394. 10.1007/s10286-021-00803-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00803-8</ArticleId><ArticleId IdType="pmc">PMC8050227</ArticleId><ArticleId IdType="pubmed">33860871</ArticleId></ArticleIdList></Reference><Reference><Citation>Stickland M. K., Butcher S. J., Marciniuk D. D., Bhutani M. (2012). Assessing exercise limitation using cardiopulmonary exercise testing. Pulm. Med. 2012, 824091. 10.1155/2012/824091</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/824091</ArticleId><ArticleId IdType="pmc">PMC3506917</ArticleId><ArticleId IdType="pubmed">23213518</ArticleId></ArticleIdList></Reference><Reference><Citation>Stickland M. K., Neder J. A., Guenette J. A., O'Donnell D. E., Jensen D. (2022). How we do it - using cardiopulmonary exercise testing to understand dyspnea and exercise intolerance in respiratory disease. Chest 161 (6), 1505&#x2013;1516. 10.1016/j.chest.2022.01.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2022.01.021</ArticleId><ArticleId IdType="pubmed">35065052</ArticleId></ArticleIdList></Reference><Reference><Citation>Stute N. L., Stickford J. L., Province V. M., Augenreich M. A., Ratchford S. M., Stickford A. S. L. (2021). COVID&#x2010;19 is getting on our nerves: sympathetic neural activity and haemodynamics in young adults recovering from SARS&#x2010;CoV&#x2010;2. J. Physiol. 599 (18), 4269&#x2013;4285. 10.1113/jp281888</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jp281888</ArticleId><ArticleId IdType="pmc">PMC8447023</ArticleId><ArticleId IdType="pubmed">34174086</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C. H., Murray B., Varsavsky T., Graham M. S., Penfold R. S., Bowyer R. C., et al. (2021). Attributes and predictors of long COVID. Nat. Med. 27 (4), 626&#x2013;631. 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Szekely Y., Lichter Y., Taieb P., Banai A., Hochstadt A., Merdler I., et al. (2020). Spectrum of cardiac manifestations in COVID-19. Circulation 142 (4), 342&#x2013;353. 10.1161/circulationaha.120.047971</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circulationaha.120.047971</ArticleId><ArticleId IdType="pmc">PMC7382541</ArticleId><ArticleId IdType="pubmed">32469253</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka H., Monahan K. D., Seals D. R. (2001). Age-predicted maximal heart rate revisited. J. Am. Coll. Cardiol. 37 (1), 153&#x2013;156. 10.1016/s0735-1097(00)01054-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0735-1097(00)01054-8</ArticleId><ArticleId IdType="pubmed">11153730</ArticleId></ArticleIdList></Reference><Reference><Citation>Tedjasaputra V., van Diepen S., Collins S. &#xc9;., Michaelchuk W. M., Stickland M. K. (2017). Assessment of pulmonary capillary blood volume, membrane diffusing capacity, and intrapulmonary arteriovenous anastomoses during exercise. J. Vis. Exp. 120, 54949. 10.3791/54949</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/54949</ArticleId><ArticleId IdType="pmc">PMC5407706</ArticleId><ArticleId IdType="pubmed">28287506</ArticleId></ArticleIdList></Reference><Reference><Citation>Tedjasaputra V., van Diepen S., Phillips D. B., Wong E. Y. L., Bhutani M., Michaelchuk W. W., et al. (2018). Pulmonary capillary blood volume response to exercise is diminished in mild chronic obstructive pulmonary disease. Respir. Med. 145, 57&#x2013;65. 10.1016/j.rmed.2018.10.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2018.10.015</ArticleId><ArticleId IdType="pubmed">30509717</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Castro R., Vasconcello-Castillo L., Alsina-Restoy X., Solis-Navarro L., Burgos F., Puppo H., et al. (2021). Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis. Pulmonology 27 (4), 328&#x2013;337. 10.1016/j.pulmoe.2020.10.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pulmoe.2020.10.013</ArticleId><ArticleId IdType="pmc">PMC7687368</ArticleId><ArticleId IdType="pubmed">33262076</ArticleId></ArticleIdList></Reference><Reference><Citation>Wensel R., Francis D. P., Meyer F. J., Opitz C. F., Bruch L., Halank M., et al. (2013). Incremental prognostic value of cardiopulmonary exercise testing and resting haemodynamics in pulmonary arterial hypertension. Int. J. Cardiol. 167 (4), 1193&#x2013;1198. 10.1016/j.ijcard.2012.03.135</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2012.03.135</ArticleId><ArticleId IdType="pubmed">22494868</ArticleId></ArticleIdList></Reference><Reference><Citation>
World Health Organization (2021). A clinical case definition of post COVID-19 condition by a delphi consensus. World Health Organization. Available at: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 (Accessed August 30, 2021). </Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>